Provider review · Updated October 15, 2026
Intentional Wellness MD microdose review: read the offer beyond the simulator
A performance-focused website describes a compounded GLP-1 service, but the public microdose record leaves the ingredient and numerical price open.
Editorial document research. No clinician review or firsthand treatment experience claimed.
Intentional Wellness MD presents care through a performance-lab vocabulary: biomarkers, simulated treatment phases and a long-term longevity timeline. The interface gives a strong sense of precision. Precision in a graphic, however, is different from a complete record of the medicine, price and evidence behind an individual treatment proposal. Those are the records this review follows.
Our October 15, 2026 check covered the provider’s homepage and GLP-1 Microdose page. We assessed public descriptions without submitting health information, testing a consultation, buying medication or evaluating patient outcomes. We also separate this publication’s disclosed CoreAge Rx promotion from the observations about Intentional Wellness MD.
Start with what the simulator represents
The homepage contains a titration and biomarker simulator alongside a display styled as live telemetry. It lets readers explore proposed phases and physiological targets. We did not identify a linked study population, analysis method or exact-product research report establishing that those displayed changes would occur for a new microdose patient.
Read the interface as the provider’s explanation of its approach. It is not a laboratory result for the visitor and does not establish a treatment effect. The lower-dose safety discussion illustrates the same distinction: a plausible account of how a program might work cannot replace evidence about its actual benefits, limitations and adverse effects.
The microdose page does not settle the ingredient question
Intentional’s microdose description calls the service a low-dose GLP-1 protocol and says partner pharmacies compound the medication. The reviewed page does not specify the active ingredient for that protocol. Its separate semaglutide and tirzepatide listings identify other programs; their names cannot simply be carried across to the microdose offer.
This is why we are reviewing the advertised service without calling it a confirmed semaglutide formulation. Ask for the medication name, preparation details and dispensing pharmacy in the actual proposal. Our dose, concentration and volume guide explains why labels describe different properties. None can be reconstructed from a general GLP-1 category or from a program’s branding.
A flat-rate promise is not yet a comparable price
The provider’s pricing language emphasizes one quoted rate, no separate consultation fee and no surcharge for dose changes. The reviewed homepage and microdose page do not provide a numerical microdose price. They direct readers to a consultation, so we cannot calculate a monthly total or establish that this offer costs less than another service.
A price-matching statement also requires terms before it becomes useful: which competing offer qualifies, what supply is compared and what is excluded? The monthly-price guide separates a rate from the billing period and amount due. CoreAge’s offer-record review is another example of why a headline and a selected agreement need their own reading.
The promoted goals extend beyond a weight-loss number
The program page positions microdosing around body composition, metabolic health and longevity, and describes combining it with other care tracks. It discusses a milder side-effect experience and changes over several months. These are the company’s proposed benefits and expectations, not findings from treatment we observed or research of the exact offered preparation that we could identify.
A clinician would need to define the purpose, how progress would be assessed and the reason for any accompanying treatment. A testimonial about tolerability cannot predict another person’s experience. AgelessRx’s offer-record review demonstrates how to keep a provider’s research-oriented language attached to the actual records behind it instead of treating all microdose programs as equivalent.
The pharmacy description does not establish product approval
Intentional describes preparation by US compounding pharmacies and refers to regulatory oversight. Oversight of a pharmacy and FDA approval of a finished medicine are different questions. FDA’s GLP-1 information identifies compounded preparations as unapproved and discusses risks that require attention to the actual prescription and dispensing record.
For this offer, the initial practical gap remains the unidentified microdose ingredient. Before drawing a medication-specific conclusion, a patient needs the proposed prescription and the pharmacy responsible for it. We do not infer an approved longevity indication, equivalent performance to an approved drug, or an individual prescription’s appropriateness from domestic sourcing. The word personalized does not resolve those questions either.
Follow-up should have an identifiable owner
The service description promises a dedicated clinician, scheduled check-ins and direct messaging. It advertises access across all 50 states. Those statements tell us how the service is presented, but we did not establish who would be assigned in a particular state, how quickly messages receive a clinical answer or how a concern is escalated.
The homepage discusses laboratory work for hormone and advanced longevity programs. That does not specify a universal laboratory requirement or included laboratory budget for the microdose program itself. Obtain the selected plan’s assessment, monitoring and follow-up terms. The offer comparison treats care access as a defined service responsibility, separate from the medication name and its advertised monthly price.
Read the exit terms before relying on flexibility
The cancellation FAQ requires notice 30 days before the next billing cycle. It also states that consultations, visits and fulfilled prescriptions become non-refundable once services begin or medication is processed. That refund language needs to be reconciled with the separate statement that consultation charges are absent; the public wording does not determine the charges in an individual agreement.
Our assessment is therefore provisional in specific ways: the numerical price, microdose ingredient and personal care arrangements require confirmation. The website supplies a service model and notice period, but its simulator does not close those gaps. Use the written prescription and agreement to make the comparison, keeping longevity and tolerability claims distinct from what has actually been documented.
Sources for this article
- Intentional Wellness MD: programs, simulator and pricing description ↗Provider service description · Checked 2026-10-15
- Intentional Wellness MD: GLP-1 Microdose program and membership FAQ ↗Provider terms and claims · Checked 2026-10-15
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss ↗Regulatory guidance · Checked 2026-10-15